{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:04Z","timestamp":1753891984608,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Recent reports have suggested that antihypertensive drugs may play an oncogenic role in common cancers, but it is still uncertain whether this could influence the risk of oral cancer. Through two-sample Mendelian randomization (MR), we sought to assess the causal effect of antihypertensive drugs on oral cancer outcomes.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> To proxy the exposure of antihypertensive drugs, we utilized two genetic instruments, including expression quantitative trait loci of drug target genes and genetic variants within or around drug target genes related to blood pressure from genome-wide association studies. Inverse-variance-weighted MR (IVW-MR) and summary-data-based MR (SMR) were employed to compute the instrument effect estimates.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> It was observed through IVW-MR analysis that there is a positive relationship between KCNH2 (target of beta-adrenoceptor blockers)\u2013mediated blood pressure and oral cancer (odds ratio [OR] = 1.197, 95% confidence interval [CI] = 1.028\u20131.394). Similarly, SMR analysis demonstrated that a higher expression of KCNH2 (target of beta-adrenoceptor blockers) was linked to a greater risk of oral cancer (OR = 2.223, 95% CI = 1.094\u20134.516). Both analyses yielded no consistent evidence of other associations.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This two-sample MR study proposed a latent causal association between KCNH2 (target of beta-adrenoceptor blockers) inhibition and diminished risk of oral cancer.<\/jats:p>","DOI":"10.3389\/fphar.2023.1294297","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T06:43:15Z","timestamp":1701067395000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between antihypertensive drugs and oral cancer: a drug target Mendelian randomization study"],"prefix":"10.3389","volume":"14","author":[{"given":"Junfeng","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rufu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0398-7620(04)99022-0","article-title":"Could treatments with beta-blockers Be associated with a reduction in cancer risk?","volume":"52","author":"Algazi","year":"2004","journal-title":"Revue d'epidemiologie de sante publique"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/jce.12178","article-title":"Differential effects of the \u0392-adrenoceptor blockers carvedilol and metoprolol on Sqt1-and sqt2-mutant channels","volume":"24","author":"Bodi","year":"2013","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet. Epidemiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12894-018-0318-7","article-title":"Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies","volume":"18","author":"Cao","year":"2018","journal-title":"BMC Urol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1358\/dot.2012.48.5.1782932","article-title":"Current status of \u0392-blockers for the treatment of hypertension: an update","volume":"48","author":"Chrysant","year":"2012","journal-title":"Drugs today (Barcelona, Spain 1998)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40256-017-0221-8","article-title":"The real role of \u0392-blockers in daily cardiovascular therapy","volume":"17","author":"D\u00e9zsi","year":"2017","journal-title":"Am. J. Cardiovasc. drugs drugs, devices, other interventions"},{"key":"B8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1593\/tlo.13346","article-title":"Exposure to acei\/arb and \u0392-blockers is associated with improved survival and decreased tumor progression and hospitalizations in patients with advanced colon cancer","volume":"6","author":"Engineer","year":"2013","journal-title":"Transl. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/s0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet (London, Engl."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million People identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in Pcsk9 and hmgcr and risk of cardiovascular disease and diabetes","volume":"375","author":"Ference","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/s0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet (London, Engl."},{"key":"B13","doi-asserted-by":"publisher","first-page":"107173","DOI":"10.1016\/j.vph.2023.107173","article-title":"The use of specific antihypertensive medication and skin cancer risk: a systematic review of the literature and meta-analysis","volume":"150","author":"Heisel","year":"2023","journal-title":"Vasc. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/bcp.12980","article-title":"Peripheral vasoconstriction induced by \u0392-adrenoceptor blockers: a systematic review and a network meta-analysis","volume":"82","author":"Khouri","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/ajh\/hpac066","article-title":"Antihypertensive drugs and cancer risk","volume":"35","author":"Kidoguchi","year":"2022","journal-title":"Am. J. Hypertens."},{"key":"B16","doi-asserted-by":"publisher","first-page":"825266","DOI":"10.3389\/fphar.2022.825266","article-title":"Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer","volume":"13","author":"Kumari","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1038\/s41440-023-01321-y","article-title":"Use of calcium channel blockers and risk of breast cancer among women aged 55 Years and older: a nationwide population-based cohort study","volume":"46","author":"Lin","year":"2023","journal-title":"Hypertens. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ijcard.2016.12.098","article-title":"Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients","volume":"230","author":"Lin","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary Artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the gbd 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat. Rev. Methods Prim."},{"key":"B23","doi-asserted-by":"publisher","first-page":"100988","DOI":"10.1016\/j.disamonth.2020.100988","article-title":"Epidemiologic aspects of oral cancer","volume":"66","author":"Sarode","year":"2020","journal-title":"Disease-a-month DM"},{"key":"B24","doi-asserted-by":"publisher","first-page":"10291","DOI":"10.1038\/s41598-020-67329-3","article-title":"Hypertension is associated with oral, laryngeal, and esophageal cancer: a nationwide population-based study","volume":"10","author":"Seo","year":"2020","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.phrs.2019.01.037","article-title":"Intriguing relationship between antihypertensive therapy and cancer","volume":"141","author":"Tadic","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fendo.2019.00056","article-title":"Evaluating all potential oral complications of diabetes mellitus","volume":"10","author":"Verhulst","year":"2019","journal-title":"Front. Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ije\/dyx207","article-title":"Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities","volume":"46","author":"Walker","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12885-023-10849-8","article-title":"Association between use of antihypertensive drugs and the risk of cancer: a population-based cohort study in shanghai","volume":"23","author":"Wang","year":"2023","journal-title":"BMC cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1177\/00220345211014795","article-title":"Oral cancer screening: past, present, and future","volume":"100","author":"Warnakulasuriya","year":"2021","journal-title":"J. Dent. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. heart J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.2105\/ajph.2018.304684","article-title":"The 20 most important and most preventable health problems of China: a delphi consultation of Chinese experts","volume":"108","author":"Wu","year":"2018","journal-title":"Am. J. public health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.18632\/aging.102699","article-title":"Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis","volume":"12","author":"Xie","year":"2020","journal-title":"Aging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1055-9965.Epi-17-1177","article-title":"Causal inference in cancer epidemiology: what is the role of mendelian randomization?","volume":"27","author":"Yarmolinsky","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1158\/1055-9965.Epi-20-1599","article-title":"Beta-blockers use and risk of breast cancer in women with hypertension","volume":"30","author":"Zheng","year":"2021","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in mendelian randomization studies","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr. Epidemiol. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from gwas and eqtl studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat. Genet."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1294297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T06:43:18Z","timestamp":1701067398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1294297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":37,"alternative-id":["10.3389\/fphar.2023.1294297"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1294297","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"article-number":"1294297"}}